Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2007 1
2011 1
2017 1
2018 1
2020 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, Ferreira U, Efstathiou E, Madziarska K, Kolinsky MP, Cubero DIG, Noerby B, Zohren F, Lin X, Modelska K, Sugg J, Steinberg J, Hussain M; PROSPER Investigators. Sternberg CN, et al. N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469184 Clinical Trial.
Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand.
Lojanapiwat B, Pripatnanont C, Choonhaklai V, Soontornpun S, Sriplakich S, Leewansangtong S, Santi-Ngamkun A, Opanuraks J, Kongcharoensombat W, Na-Songkla B, Raksakul W, Predanon C. Lojanapiwat B, et al. Among authors: sriplakich s. Prostate Int. 2017 Mar;5(1):1-7. doi: 10.1016/j.prnil.2017.01.002. Epub 2017 Jan 11. Prostate Int. 2017. PMID: 28352616 Free PMC article. Review.
Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort.
Lim J, Amantakul A, Shariff N, Lojanapiwat B, Alip A, Ong TA, Thevarajah S, Ahmayuddin F, Mathew A, Sriplakich S, Vuthiwong J, Chong FLT, Saad M. Lim J, et al. Among authors: sriplakich s. Cancer Med. 2020 Jul;9(13):4613-4621. doi: 10.1002/cam4.3101. Epub 2020 May 6. Cancer Med. 2020. PMID: 32374087 Free PMC article.
Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4-10 ng/mL and negative digital rectal examination.
Sriplakich S, Lojanapiwat B, Chongruksut W, Phuriyaphan S, Kitirattakarn P, Jun-Ou J, Amantakul A. Sriplakich S, et al. Prostate Int. 2018 Dec;6(4):136-139. doi: 10.1016/j.prnil.2018.02.002. Epub 2018 Feb 15. Prostate Int. 2018. PMID: 30505815 Free PMC article.